Core Scientific Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Revenue	502.4	640.31	544.48	60.32
Revenue Growth (YoY)	-21.54%	17.60%	802.66%	-
Cost of Revenue	378.94	631.91	305.62	50.93
Gross Profit	123.46	8.4	238.86	9.39
Selling, General & Admin	100.93	226.01	64.55	16.33
Research & Development	7.18	26.96	7.67	5.27
Other Operating Expenses	2.47	1,865	35.15	-5.88
Operating Expenses	110.58	2,118	107.37	15.72
Operating Income	12.88	-2,109.55	131.49	-6.33
Interest Expense / Income	86.24	96.83	44.35	4.44
Other Expense / Income	172.45	-42.97	24.07	1.44
Pretax Income	-245.8	-2,163.41	63.08	-12.21
Income Tax	0.68	-17.09	15.76	0
Net Income	-246.49	-2,146.32	47.31	-12.21
Preferred Dividends	0	0	0	10.48
Net Income Common	-246.49	-2,146.32	47.31	-22.68
Shares Outstanding (Basic)	380	341	207	-
Shares Outstanding (Diluted)	380	341	233	-
Shares Change	11.51%	46.01%	-	-
EPS (Basic)	-0.65	-6.30	0.23	-0.14
EPS (Diluted)	-0.65	-6.30	0.20	-0.14
Free Cash Flow	48.12	-396.47	-56.03	-25.33
Free Cash Flow Per Share	0.13	-1.16	-0.27	-
Gross Margin	24.57%	1.31%	43.87%	15.57%
Operating Margin	2.56%	-329.46%	24.15%	-10.49%
Profit Margin	-49.06%	-335.20%	8.69%	-37.61%
Free Cash Flow Margin	9.58%	-61.92%	-10.29%	-42.00%
Effective Tax Rate	-	-	24.99%	-
EBITDA	-63.12	-1,840.49	140.79	1.63
EBITDA Margin	-12.56%	-287.44%	25.86%	2.71%
Depreciation & Amortization	96.45	226.09	33.36	9.4
EBIT	-159.57	-2,066.58	107.43	-7.77
EBIT Margin	-31.76%	-322.75%	19.73%	-12.88%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).